Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db mice
- 16 June 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 344 (4), 1224-1233
- https://doi.org/10.1016/j.bbrc.2006.04.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonistBiochemical and Biophysical Research Communications, 2005
- Pancreatic Islet Renin Angiotensin SystemPancreas, 2005
- Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic β-cell line, MIN6—a role of NAD(P)H oxidase in β-cellsBiochemical and Biophysical Research Communications, 2004
- Microvascular development: learning from pancreatic isletsBioEssays, 2004
- Diabetes and mitochondrial bioenergetics: Alterations with ageJournal of Biochemical and Molecular Toxicology, 2003
- Angiotensin II Inhibits Endothelial Cell Motility Through an AT1-Dependent Oxidant-Sensitive Decrement of Nitric Oxide AvailabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Local Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of RatsHypertension, 2000
- Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.Journal of Clinical Investigation, 1997
- Studies in the diabetic mutant mouse: II. Electron microscopy of pancreatic isletsDiabetologia, 1970
- Studies in the diabetic mutant mouse: I. Light microscopy and radioautography of pancreatic isletsDiabetologia, 1970